NCT07218029

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2021-05-12Est. Completion: 2028-12-07

Enrollment target: 815 participants

Locations

Pulmonary Associates, PA ( Site 1008), Phoenix, Arizona, United States
Arizona Pulmonary Specialists ( Site 1010), Scottsdale, Arizona, United States
University of California San Diego Health ( Site 1002), La Jolla, California, United States
UC Irvine Health Medical Center ( Site 1086), Orange, California, United States
UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019), San Francisco, California, United States
Jeffrey S. Sager, MD Medical Corporation ( Site 1060), Santa Barbara, California, United States
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 1028), Torrance, California, United States
University of Colorado Hospital ( Site 1013), Aurora, Colorado, United States
Mayo Clinic Jacksonville ( Site 1045), Jacksonville, Florida, United States
AdventHealth Orlando ( Site 1058), Orlando, Florida, United States
Tampa General Hospital ( Site 1043), Tampa, Florida, United States
University of Kansas Medical Center ( Site 1020), Kansas City, Kansas, United States
Norton Pulmonary Specialists ( Site 1066), Louisville, Kentucky, United States

Heart Failure

Background: More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…

Falls Church, United StatesCompleted Apr 30, 2028

Chronic Obstructive Pulmonary Disease (COPD)Asthma (Diagnosis)Interstitial Lung Disease (ILD)BronchiectasisBreathing Pattern Disorder

Breathlessness is a complex symptom that results in poor quality of life, increased hospitalisations and increased morta…

Leicester, United KingdomEst. completion Jul 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.